Central chondrosarcoma and cholangiocarcinoma predominantly harbour R132C mutations in IDH1 (50%), glioma has mainly R132H mutations in IDH1 (90%) and AML has most often R140Q mutations in IDH2 (30–50%) [62]. This evidence concerns the gene IDH1 and cholangiocarcinoma.